Cargando…
Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic Models
BACKGROUND AND OBJECTIVES: Siponimod is an oral, selective sphingosine-1-phosphate receptor-1/5 modulator approved for treatment of multiple sclerosis. METHODS: Mouse MRI was used to investigate remyelination in the cuprizone model. We then used a conditional demyelination Xenopus laevis model to as...
Autores principales: | Dietrich, Michael, Hecker, Christina, Martin, Elodie, Langui, Dominique, Gliem, Michael, Stankoff, Bruno, Lubetzki, Catherine, Gruchot, Joel, Göttle, Peter, Issberner, Andrea, Nasiri, Milad, Ramseier, Pamela, Beerli, Christian, Tisserand, Sarah, Beckmann, Nicolau, Shimshek, Derya, Petzsch, Patrick, Akbar, David, Levkau, Bodo, Stark, Holger, Köhrer, Karl, Hartung, Hans-Peter, Küry, Patrick, Meuth, Sven Günther, Bigaud, Marc, Zalc, Bernard, Albrecht, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969301/ https://www.ncbi.nlm.nih.gov/pubmed/35354603 http://dx.doi.org/10.1212/NXI.0000000000001161 |
Ejemplares similares
-
Siponimod Modulates the Reaction of Microglial Cells to Pro-Inflammatory Stimulation
por: Gruchot, Joel, et al.
Publicado: (2022) -
The Molecular Basis for Remyelination Failure in Multiple Sclerosis
por: Gruchot, Joel, et al.
Publicado: (2019) -
Central Versus Peripheral Drug Exposure Ratio, a Key Differentiator for Siponimod Over Fingolimod?
por: Bigaud, Marc, et al.
Publicado: (2023) -
Monitoring recovery after CNS demyelination, a novel tool to de-risk pro-remyelinating strategies
por: Henriet, Esther, et al.
Publicado: (2023) -
From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases
por: Dubois-Dalcq, Monique, et al.
Publicado: (2008)